Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
News Type
News Topics
- (-) Coronavirus (1)
- (-) Quantum Science (1)
- 3-D Printing/Advanced Manufacturing (1)
- Artificial Intelligence (2)
- Biology (2)
- Biomedical (1)
- Chemical Sciences (1)
- Computer Science (3)
- Fusion (1)
- High-Performance Computing (1)
- Materials (2)
- Materials Science (4)
- Microscopy (1)
- Nanotechnology (1)
- Neutron Science (6)
- Quantum Computing (1)
Media Contacts
A team led by the U.S. Department of Energy’s Oak Ridge National Laboratory demonstrated the viability of a “quantum entanglement witness” capable of proving the presence of entanglement between magnetic particles, or spins, in a quantum material.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.